Loading...
INCB057643, a bromodomain and extra-terminal protein inhibitor, in combination with ruxolitinib in patients with myelofibrosis: a phase 1 study of safety and efficacy
Watts, J. Hunter, A. Yuda, J. Abdulgawad, A. Halpern, A. Casares, M. T. G. Ritchie, E. Diaz, R. A. Palandri, F. Iurlo, A.
Watts, J.
Hunter, A.
Yuda, J.
Abdulgawad, A.
Halpern, A.
Casares, M. T. G.
Ritchie, E.
Diaz, R. A.
Palandri, F.
Iurlo, A.
Abstract
Authors
Watts, J.
Hunter, A.
Yuda, J.
Abdulgawad, A.
Halpern, A.
Casares, M. T. G.
Ritchie, E.
Diaz, R. A.
Palandri, F.
Iurlo, A.
Rivas, J. M. H.
Gupta, V.
Kirito, K.
Reeves, B.
Vachhani, P.
Bose, P.
Bonifacio, M.
McMahon, B.
Tantravahi, S.
Choi, J.
Lucchesi, A.
Poonsombudlert, K.
Burke, L.
Zhou, F.
Zheng, F.
Vannucchi, A. M.
Hunter, A.
Yuda, J.
Abdulgawad, A.
Halpern, A.
Casares, M. T. G.
Ritchie, E.
Diaz, R. A.
Palandri, F.
Iurlo, A.
Rivas, J. M. H.
Gupta, V.
Kirito, K.
Reeves, B.
Vachhani, P.
Bose, P.
Bonifacio, M.
McMahon, B.
Tantravahi, S.
Choi, J.
Lucchesi, A.
Poonsombudlert, K.
Burke, L.
Zhou, F.
Zheng, F.
Vannucchi, A. M.
Description
Date
2025
Publisher
Collections
Files
Loading...
Found from Unpaywall
Adobe PDF, 174.52 KB
Keywords
Type
Article
Citation
Watts J, Hunter A, Yuda J, Abdulgawad A, Halpern A, Casares MTG, et al. INCB057643, a bromodomain and extra-terminal protein inhibitor, in combination with ruxolitinib in patients with myelofibrosis: a phase 1 study of safety and efficacy. Blood. 2025 NOV 3;146:5574-5.